Mount Sinai Researchers Study SARS-CoV2 caused MIS-C

Study published in Cell, documents presence of concerning autoantibodies

Research Alert

Newswise — In a study published today, entitled Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C), researchers with the Icahn School of Medicine at Mount Sinai present the first comprehensive report of a systemic immune profiling of the Multisystem Inflammatory Syndrome in Children (MIS-C). Their deep dive into the immune profiles of nine cases provides a comparison between MIS-C, healthy children and individuals with COVID-19. The study also identifies autoantibodies targeting organ systems central to the pathology of MIS-C. 

“It is our hope that recurrence of MIS-C will be rare, as is the case with Kawasaki disease. However, our documentation of the presence of autoantibodies, which attack the host’s tissues or organs, raises a red flag. We postulate that these autoantibodies trigger immune complex formation and may unleash an immune cell-driven attack against host tissues. This postulation – which we hope to investigate further – concerns us as it may pose a risk for children when a vaccine becomes available,” says corresponding author, Dusan Bogunovic, PhD, Associate Professor, Microbiology and Pediatrics, Icahn School of Medicine at Mount Sinai. 

“Our analysis lays the foundation for future investigations into MIS-C. In our lab, our next focus will be learning how to recognize this syndrome and identify ways to prevent it. This work will in turn pave the way for a much needed prevention algorithm,” says Roosheel Patel, a PhD candidate who jointly led this study with Conor Gruber, an MD/PhD candidate, both of whom are studying at the Icahn School of Medicine at Mount Sinai.

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 5391
Released: 13-Apr-2021 4:05 PM EDT
B.1.1.7. variant more transmissible, does not increase severity, Lancet studies suggest
Lancet

An observational study of patients in London hospitals suggests that the B.1.1.7. variant is not associated with more severe illness and death, but appears to lead to higher viral load, consistent with emerging evidence that this lineage is more transmissible than the original COVID-19 strain.

Newswise: Plasma device designed for consumers can quickly disinfect surfaces
Released: 13-Apr-2021 3:05 PM EDT
Plasma device designed for consumers can quickly disinfect surfaces
Princeton Plasma Physics Laboratory

The COVID-19 pandemic has cast a harsh light on the urgent need for quick and easy techniques to sanitize and disinfect everyday high-touch objects such as doorknobs, pens, pencils, and personal protective gear worn to keep infections from spreading.

Newswise: Narratives Can Help Science Counter Misinformation on Vaccines
Released: 13-Apr-2021 12:50 PM EDT
Narratives Can Help Science Counter Misinformation on Vaccines
Iowa State University

Narratives are a powerful tool that can help explain complex issues, but they can also serve as sources of misinformation, which presents a challenge as public health agencies work to educate people about COVID-19 vaccine.

Released: 13-Apr-2021 10:05 AM EDT
Puerto Rico, Coronavirus Among Top Latino Twitter Topics During 2020 Election
George Washington University

Latinos discussed Puerto Rico and the COVID-19 pandemic more than any other subject on Twitter in the run-up to the 2020 election, according to researchers at the George Washington University. Spanish-language tweets mentioning “freedom” and “socialism” were also popular, while topics such as Obamacare and immigration did not gain much traction.

Newswise: Americans continue struggling for a good night’s sleep during the pandemic
Released: 13-Apr-2021 9:00 AM EDT
Americans continue struggling for a good night’s sleep during the pandemic
American Academy of Sleep Medicine (AASM)

The coronavirus pandemic continues to have a negative impact on our sleep, according to new findings from the American Academy of Sleep Medicine.

Newswise:Video Embedded the-science-behind-the-shot-biotech-tools-developed-at-brookhaven-lab-fundamental-to-making-covid-19-vaccines
VIDEO
Released: 13-Apr-2021 8:05 AM EDT
The Science Behind the Shot: Biotech Tools Developed at Brookhaven Lab Fundamental to Making COVID-19 Vaccines
Brookhaven National Laboratory

You’ve probably heard that the first two vaccines approved for battling COVID-19 in the United States use a relatively new approach—injections of simple packets containing mRNA, a genetic material that instructs our cells to make coronavirus spike proteins. But the technology for generating sufficient amounts of those mRNA packets dates back to the 1980s, when F. William Studier, then a senior biophysicist at the U.S. Department of Energy’s Brookhaven National Laboratory, developed a way to harness the molecular machinery of a very different virus.

Newswise: UCLA Fielding School of Public Health Scholar’s Work on Fatigue and Health Published
Released: 13-Apr-2021 4:05 AM EDT
UCLA Fielding School of Public Health Scholar’s Work on Fatigue and Health Published
UCLA Fielding School of Public Health

A landmark work has been published examining fatigue as a hugely important factor in human health and extremely relevant to those with “long-haul” COVID-19 symptoms.

access_time Embargo lifts in 2 days
Embargo will expire: 14-Apr-2021 2:00 PM EDT Released to reporters: 12-Apr-2021 4:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Apr-2021 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 5391

close
1.65505